ArticleRespiratory research2026
Clinical and genetic features of idiopathic pulmonary fibrosis in a Korean cohort.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A SNP altering the MUC5AC mucin structure is increased in idiopathic pulmonary fibrosis together with the MUC5B SNP.Respiratory research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic pulmonary fibrosis (IPF) is characterized by substantial genetic heterogeneity across populations, yet genetic features in Asian populations remain underexplored. This study aimed to describe the clinical and genetic landscape of Korean IPF patients and compare findings with reference populations.
methodsThe authors analyzed 107 Korean IPF patients from Severance Hospital (2012-2023), including 19 (17.8%) with family history of IPF. Genomic DNA was genotyped using Illumina Multi-Ethnic Genotyping Array. Allele frequencies of 28 IPF-associated SNPs were compared to global and Korean reference populations, and variants within 29 IPF-related genes were analyzed by Fisher’s exact tests. Clinical outcomes (survival and longitudinal lung function) were compared between familial and sporadic IPF using Kaplan-Meier and mixed-effects models.
resultsAmong 107 Korean IPF patients (19 familial, 88 sporadic), three notable findings emerged. First, population-specific SNP differences were observed, with significant depletion of IPF risk variants such as TERT rs2736100 and FAM13A rs2609255 compared with Korean and global reference populations. Second, familial IPF cases showed significantly faster physiological decline, with greater reductions in FVC (−2.36%/year) and DLCO (−4.44%/year), although survival differences were not statistically significant. Third, systematic variant analysis identified 22 potentially pathogenic variants across 7 IPF-related genes, with the highest proportion in epithelial–mesenchymal transition (45.5%) and DNA repair/telomere maintenance (27.3%) pathways, in contrast to the surfactant gene–driven architecture frequently reported in Western cohorts.
conclusionsThis descriptive study outlines the clinical and genetic features of Korean IPF patients, highlighting population-specific genomic patterns, more rapid physiological decline in familial cases, and a diverse distribution of potentially pathogenic variants. These findings underscore the importance of incorporating diverse populations into IPF genetic research to refine understanding of disease mechanisms and to inform the development of population-appropriate therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.